Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (9)

2023

  1. Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity

    Clinical and Translational Oncology, Vol. 25, Núm. 11, pp. 3073-3085

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2021

  1. Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 438-448

2019

  1. Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 749-759

  2. Current Status of Cardio-Oncology in Spain: A National Multidisciplinary Survey

    Revista Espanola de Cardiologia, Vol. 72, Núm. 1, pp. 84-86

  3. Replied to “Some remarks to SEOM clinical guidelines on cardiovascular toxicity (2018)”

    Clinical and Translational Oncology

  4. SEOM clinical guidelines on cardiovascular toxicity (2018)

    Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 94-105

2018

  1. Selection of the Best of 2017 on Cardio-oncology. What Should We Know?

    Revista Espanola de Cardiologia, Vol. 71, Núm. 1, pp. 61

2017

  1. Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 70, Núm. 6, pp. 474-486